RSS
Tourism: Pilot-programme carried out in spa resorts to capitalize on the Ana Aslan brand
The Spa Tourism Employers Association (OPTBR), backed by the National Tourism Association (ANT), has recently, initiated in partnership with the National Institute of Gerontology and Geriatrics and the Ana Aslan Foundation a pilot-programme meant to promote treatments of this type and to revitalize the famous Romanian brand Ana Aslan.
According to a press release of the initiators, the Romanian Medical Tourism Association (ARTM) and the despreSpa.ro team have also participated in the realization and promotion of this project.
At the inauguration event, organised in the Baile Tusnad resort (central Romania), participants talked about the power of the Ana Aslan brand, about the effects of geriatric treatments and also about geriatric treatments as a new opportunity for development of the spa tourism.
'The development of this geriatric programmes for attracting Romanian and foreign tourists, by capitalizing on the notoriety and the efficiency of the Ana Aslan brand, is part of the national strategy of development of the spa and health tourism. That's why we hope that we will be able to expand the geriatric programme that we launched at the O3Zone hotel to other hotels in the OPTBR network too,' it was said in the abovementioned release.
The pilot-programme includes two programmes in fact ('Live Young' and 'Relaxation. Rebalancing. Revitalization') and it will be carried out at the O3Zone Hotel, whose guests will benefit from free access to the swimming pool, jacuzzi, dry and wet sauna and to the gym all at the SPA centre.
The Ana Aslan therapy includes preventive or curative treatment with products from the Gerovital H3 range, personalized depending on the age and pathology of the patient.
'A biologist and a physician, Ana Aslan recommended her patients to begin the therapy at the age of 40. Treatment is recommend for a wide range of problems associated with the degenerative process specific to the aging women: rheumatism, peripheral circulatory disorders, depression, hypertension, atherosclerosis,' according to the ARTM.
Ana Aslan (1897-1988, born in Braila) studied at the Faculty of Medicine in Bucharest (1915-1922). She was professor of Cardiology at the Faculty of Medicine in Timisoara (1945-1949). Between 1949 and 1952 she was head of department at the Institute of Endocrinology in Bucharest. Starting in 1952 she became General Director of the Institute of Geriatrics. As one of the pioneering scientists in the world on medical gerontology, Ana Aslan focused also on social gerontology.
She discovered the anti-aging effects of procaine, based on which she developed the drugs Gerovital H3 and Aslavital.
The Gerovital H3 is the first Romanian original biotrophic product and also the first medicine designed to delay human aging processes. It was developed between 1946 and 1956 by Prof. Ana Aslan and her followers, as a result of numerous clinical and experimental studies.